Home/Publication/CBC & Mubadala in Neurology and Allergy Play
CBC & Mubadala in Neurology and Allergy Play 

27 Aug 2024

US$ 19.00

CBC Group and Mubadala Investment Co have agreed to buy the neurology and allergy business in China from UCB SA ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Warburg Pincus LLC announced a strategic investment in Haier India, the Indian subsidiary of China’s global home a...

Hong Kong’s Sun Hung Kai & Co Ltd, an established investment holding company, is to commit US$100 m in the US$7.9 bn t...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.